Johannes Khinast
Professor of Pharmaceutical Engineering at Graz University of Technology and CEO of RCPE
Meet Johannes Khinast
Khinast has almost 300 publications in refereed journals and 10 patents registered under his name, and has worked with numerous pharmaceutical companies as an advisor for the implementation of novel drug formulations. “Pharma will look back on COVID-19 as a game-changer that hopefully brought back API production to Europe. We will be better prepared to face another health crisis in the future by reacting faster and making rapidly invented drugs accessible for a large number of people around the world.”